Persistent growth impairment of bone marrow stroma after antilymphocyte globulin treatment for severe aplastic anaemia and its association with relapse.

作者: C. Nissen , A. Wodnar-Filipowicz , M. Slanicka Krieger , A. Gratwohl , A. Tichelli

DOI: 10.1111/J.1600-0609.1995.TB00268.X

关键词: Bone marrowPrecursor cellBiologyStromaHaematopoiesisAplasiaImmunosuppressionAplastic anemiaChemotherapyPathology

摘要: :  Bone marrow from 65 patients with aplastic anaemia (AA) was tested for stroma growth in short term cultures (2 weeks) and colony formation by haemopoietic precursor cells during the course of their disease. In 18 untreated patients, mean 30% normal virtually absent. After treatment immunosuppression (IS), as estimated 90 examinations 54 approximately 50% 10% normal. Growth impairment precursors persisted 10 more years after IS. Results 2-week were compared results long bone AA 4 controls. At 2 weeks, delayed to normal, but this difference became less evident prolonged incubation time. vitro abnormalities clinical evolution The development late haematological complications (paroxysmal nocturnal haemoglobinuria (PNH)) myelodysplastic syndrome (MDS), did not correlate degree impairment. However, relapse aplasia associated poor growth: 8/29 confluence ≤30% remission versus 1/25 >30% relapsed. We conclude that (i) haematopoietic microenvironment is frequently coinvolved disease process AA, (ii) a defect detected rather than and, (iii) frequent growth.

参考文章(33)
Bruce M. Camitta, Rainer Storb, E. Donnall Thomas, Aplastic anemia (first of two parts): pathogenesis, diagnosis, treatment, and prognosis. The New England Journal of Medicine. ,vol. 306, pp. 645- 652 ,(1982) , 10.1056/NEJM198203183061105
R Andreesen, W Brugger, C Thomssen, A Rehm, B Speck, GW Lohr, Defective monocyte-to-macrophage maturation in patients with aplastic anemia. Blood. ,vol. 74, pp. 2150- 2156 ,(1989) , 10.1182/BLOOD.V74.6.2150.2150
R. Stark, C. Andre, D. Thierry, M. Cherel, F. Galibert, E. Gluckman, The expression of cytokine and cytokine receptor genes in long-term bone marrow culture in congenital and acquired bone marrow hypoplasias. British Journal of Haematology. ,vol. 83, pp. 560- 566 ,(1993) , 10.1111/J.1365-2141.1993.TB04691.X
Richard Champlin, Winston Ho, Robert Peter Gale, Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial. The New England Journal of Medicine. ,vol. 308, pp. 113- 118 ,(1983) , 10.1056/NEJM198301203080301
A Gratwohl, C Nissen, U Leibundgut, D Ruggero, B Osterwalder, H P Burri, P Cornu, M Jeannet, B Speck, Treatment of severe aplastic anaemia with antilymphocyte globulin or bone-marrow transplantation. BMJ. ,vol. 282, pp. 860- 863 ,(1981) , 10.1136/BMJ.282.6267.860
F. M. Gibson, E. C. Gordon-Smith, Long‐term culture of aplastic anaemia bone marrow British Journal of Haematology. ,vol. 75, pp. 421- 427 ,(1990) , 10.1111/J.1365-2141.1990.TB04358.X
Malcolm A.S. Moore, Hugo Castro-Malaspina, Immunosuppression in Aplastic Anemia — Postponing the Inevitable? New England Journal of Medicine. ,vol. 324, pp. 1358- 1360 ,(1991) , 10.1056/NEJM199105093241909
B. Speck, E. Gluckman, H.L. Hark, J.J. Van Rood, Treatment of aplastic anaemia by antilymphocyte globulin with and without allogeneic bone-marrow infusions. The Lancet. ,vol. 310, pp. 1145- 1148 ,(1977) , 10.1016/S0140-6736(77)91537-9